- Home
- Gastroenterology
- Fidaxomicin as a First-Line Option to Reduce Recurrence in Clostridioides difficile Infection

1w3 min read
Medical Article
Introduction Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated infectious diarrhoea worldwide (1). The burden is substantial, with over 500,000 cases annually in the United States alone and significant mortality among hospitalized and elderly populations (1). Although several antibiotics achieve initial resoluti

Fidaxomicin as a First-Line Option to Reduce Recurrence in Clostridioides difficile Infection
441 Reached1 Comments
Similar Content

Single-incision Laparoscopy for Gastrostomy
408 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
863 Reached30 Comments15 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1866 Reached17 Comments9 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Infant with Congenital Diaphragmatic Hernia (CDH)
6976 Reached14 Comments8 Likes